Bill Sponsor
House Bill 2366
117th Congress(2021-2022)
STOP Fentanyl Act of 2021
Introduced
Introduced
Introduced in House on Apr 5, 2021
Overview
Text
Introduced
Apr 5, 2021
Latest Action
Oct 19, 2021
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
2366
Congress
117
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
New Hampshire
Democrat
California
Democrat
Florida
Democrat
Maryland
Democrat
Minnesota
Republican
Nebraska
Democrat
New York
Democrat
New York
Democrat
Pennsylvania
House Votes (0)
Senate Votes (0)
No House votes have been held for this bill.
Summary

Support, Treatment, and Overdose Prevention of Fentanyl Act of 2021 or the STOP Fentanyl Act of 2021

This bill addresses data collection, treatment, harm reduction, and other issues related to substance misuse and addiction. It particularly focuses on opioids, fentanyl, and related substances.

Specifically, the bill expands surveillance of fentanyl and related substances. This includes establishing a pilot program to screen for contaminants in illicit drugs and a grant program to collect data on fentanyl-involved overdoses. The bill also specifies requirements concerning the collection and use of information about drugs seized by law enforcement.

Additionally, the bill establishes and modifies requirements to increase access to treatment and prevention services. For example, the Bureau of Prisons must make certain services, including medication-assisted treatments, available to individuals in its custody. The bill also

  • repeals a provision that requires dependence on opioids for at least one year before an individual may be admitted to certain treatment programs;
  • allows providers to prescribe medications to treat substance use disorders following a telehealth evaluation;
  • creates grant programs for treatment and harm reduction activities; and
  • addresses issues pertaining to opioid overdose reversal drugs.

Furthermore, the bill limits civil and criminal liability under specified laws for individuals who administer opioid overdose reversal drugs to an individual who reasonably appears to be experiencing an overdose, as well as for individuals who seek medical attention for themselves or on behalf of another for a drug overdose.

The bill also requires multiple reports, including a report by the Department of State on foreign sources of certain drugs.

Text (1)
April 5, 2021
Actions (4)
10/19/2021
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
04/13/2021
Referred to the Subcommittee on Health.
04/05/2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
04/05/2021
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:48:53 PM